Skip to NavigationSkip to content

News

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be making in...
A new study by scientists in Australia has put forward an explanation for why current approaches have failed to produce progress in dementia and...
Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).
Barcelona will play host to Veeva R&D Summit, Europe next month. This annual conference will be the place for more than 350 European R...
In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – with sales of the generics...
An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s Health Secretary, said that 270...
Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor, investigating its efficacy in non-small cell...
Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of accounting rules by the...
Aaron Traywick, who made headlines when he injected himself with an untested DIY herpes vaccine during a live streaming session on Facebook back in...
Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of relapsed or refractory...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches